CCCristina Siles Cuesta
Cristina Siles Cuesta
*This is an algorithmically generated author record based on publicly available information.
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Cristina Siles Cuesta has a total of 23 co-authors. Here are the top co-authors by number of shared publications:
- Ariadna Lloansí
Amgen S.A., Plaça del Gas, 1, 08003 Barcelona, Spain
2 shared publications - Cristina Teixidó
Molecular Biology CORE, Hospital Clínic de Barcelona, Barcelona 08036, Spain
2 shared publications - Daniel Martinez
Hospital Clínic de Barcelona, FCRB-IDIBAPS, University of Barcelona, Carrer de Villarroel, 170, 08036 Barcelona, Spain
2 shared publications - Edurne Arriola
Department of Medical Oncology, Hospital del Mar, Spain
2 shared publications - Francesc Cots
Hospital del Mar-CIBERONC, Passeig Marítim de la Barceloneta, 25, 08003 Barcelona, Spain
2 shared publications - Joan Sánchez
Hospital Clínic de Barcelona, FCRB-IDIBAPS, University of Barcelona, Carrer de Villarroel, 170, 08036 Barcelona, Spain
2 shared publications
Latest Publications
- Open Access
- 8 October 2025
- Published by Elsevier in Lung Cancer
- Vol. 209, 108790
Corrigendum to ”Characterization and economic burden of KRASG12C-mutant lung cancer in real-world Spanish practice: a retrospective observational study (SILK study)” [Lung Cancer 206 (2025) 108677]
- 8 October 2025
- Published by Elsevier in Lung Cancer
- Vol. 209, 108790
Open AccessCorrigendum to ”Characterization and economic burden of KRASG12C-mutant lung cancer in real-world Spanish practice: a retrospective observational study (SILK study)” [Lung Cancer 206 (2025) 108677]
- Open Access
- 22 July 2025
- Published by Elsevier in Lung Cancer
- Vol. 206, 108677
Characterization and economic burden of KRASG12C-mutant lung cancer in real-world Spanish practice: a retrospective observational study (SILK study)
- 22 July 2025
- Published by Elsevier in Lung Cancer
- Vol. 206, 108677
Open AccessCharacterization and economic burden of KRASG12C-mutant lung cancer in real-world Spanish practice: a retrospective observational study (SILK study)